Insiders · Profile

Davis Thomas Andrew

Sr. VP & CMO at Celldex Therapeutics. Filing since 16 Sep 2010. CIK 0001338185

Company

Date

Role

Action

Shares

Amount

Of holding

CLDX Celldex Therapeutics, Inc.

16 Sep 2010

Sr. VP & CMO

Bought

2,500

$9.44K

opened

1 decision on file.